Thomas R. Coleman

7.9k total citations · 2 hit papers
54 papers, 5.2k citations indexed

About

Thomas R. Coleman is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Thomas R. Coleman has authored 54 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Cell Biology and 13 papers in Hematology. Recurrent topics in Thomas R. Coleman's work include Erythropoietin and Anemia Treatment (13 papers), Erythrocyte Function and Pathophysiology (8 papers) and Microtubule and mitosis dynamics (8 papers). Thomas R. Coleman is often cited by papers focused on Erythropoietin and Anemia Treatment (13 papers), Erythrocyte Function and Pathophysiology (8 papers) and Microtubule and mitosis dynamics (8 papers). Thomas R. Coleman collaborates with scholars based in United States, Italy and Türkiye. Thomas R. Coleman's co-authors include William G. Dunphy, Paul R. Mueller, Michael Brines, Akiko Kumagai, Anthony Cerami, Phillip B. Carpenter, Pietro Ghezzi, Mark S. Mooseker, Tiziana Mennini and Pia Villa and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas R. Coleman

53 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15

1995 558 citations Paul R. Mueller, Thomas R. Coleman et al. profile →
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

2004 527 citations Michael Brines, Giovanni Grasso et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Thomas R. Coleman

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Coleman more than expected).

Fields of papers citing papers by Thomas R. Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Coleman. The network helps show where Thomas R. Coleman may publish in the future.

Co-authorship network of co-authors of Thomas R. Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Coleman. A scholar is included among the top collaborators of Thomas R. Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Coleman. Thomas R. Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates 2022 ·Nature Communications ·(unknown), Mingzhu He, Sonya VanPatten, Kai Cheng, Umair Ahmed, (unknown), Ibrahim T. Mughrabi, (unknown), Ronald M. Burch, Kirk R. Manogue, Kevin J. Tracey, Betty Diamond, Christine N. Metz, Huan Yang, LaQueta Hudson, Stavros Zanos, Myoungsun Son, Barbara Sherry, Thomas R. Coleman, Yousef Al‐Abed	7
2	Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation 2019 ·Nature Communications ·Victoria Cotero, Ying Fan, Téa Tsaava, Adam M. Kressel, Ileana Hancu, Paul B. Fitzgerald, Kirk Wallace, Sireesha Kaanumalle, John Graf, (unknown), Tzu‐Jen Kao, Jeannette C. Roberts, Chitresh Bhushan, Suresh Joel, Thomas R. Coleman, Stavros Zanos, Kevin J. Tracey, Jeffrey Ashe, Sangeeta S. Chavan, Chris Puleo	133
3	C1q and HMGB1 reciprocally regulate human macrophage polarization 2016 ·Blood ·Myoungsun Son, (unknown), Mingzhu He, Jolien Suurmond, Frances Santiago‐Schwarz, Jan Andersson, Thomas R. Coleman, Bruce T. Volpe, Kevin J. Tracey, Yousef Al‐Abed, Betty Diamond	140
4	Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential 2016 ·Journal of Biological Chemistry ·(unknown), Christine N. Metz, Saisha Nalawade, (unknown), Kai Cheng, Mingzhu He, Barbara Sherry, Thomas R. Coleman, Thomas G. Forsthuber, Yousef Al‐Abed	54
5	Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models 2016 ·Physiological Reports ·Mohamed Ahmed, Sonya VanPatten, Satyan Lakshminrusimha, Hardik Patel, Thomas R. Coleman, Yousef Al‐Abed	7
6	Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities 2006 ·Proceedings of the National Academy of Sciences ·Thomas R. Coleman, Christof Westenfelder, Florian Tögel, Ying Yang, Zhuma Hu, (unknown), Henri G. D. Leuvenink, Rutger J. Ploeg, Livius V. d’Uscio, Zvonimir S. Katušić, Pietro Ghezzi, Adriana Zanetti, Kenneth Kaushansky, Norma E. Fox, Anthony Cerami, Michael Brines	101
7	Carbamylated Erythropoietin Reduces Radiosurgically-Induced Brain Injury 2006 ·Molecular Medicine ·Serhat Erbayraktar, Nihal de Lanerolle, Alain de Lotbinière, Jonathan Knisely, Zübeyde Erbayraktar, Osman Yılmaz, Anthony Cerami, Thomas R. Coleman, Michael Brines	40
8	Erythropoietin, Modified to Not Stimulate Red Blood Cell Production, Retains Its Cardioprotective Properties 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Chanil Moon, Melissa Krawczyk, Doo‐Jin Paik, Thomas R. Coleman, Michael Brines, Magdalena Juhaszova, Steven J. Sollott, Edward G. Lakatta, Mark I. Talan	73
9	Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor breakdown → 2004 ·Proceedings of the National Academy of Sciences ·Michael Brines, Giovanni Grasso, Fabio Fiordaliso, Alessandra Sfacteria, Pietro Ghezzi, Maddalena Fratelli, Roberto Latini, (unknown), John E. Smart, (unknown), Eileen G. Pobre, Deborah Diaz, Daniel E. Gómez, (unknown), Thomas R. Coleman, Anthony Cerami	527
10	Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinity 2004 ·Bioorganic & Medicinal Chemistry Letters ·A. Gilbert, Thomas R. Coleman, (unknown), Richard E. Mewshaw, Rosemary Scerni, Lee E. Schechter, Deborah L. Smith, Terrance H. Andree	9
11	Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis 2003 ·The Journal of Experimental Medicine ·Pia Villa, Paolo Bigini, Tiziana Mennini, Davide Agnello, Teresa Laragione, Alfredo Cagnotto, Barbara Viviani, Marina Marinovich, Anthony Cerami, Thomas R. Coleman, Michael Brines, Pietro Ghezzi	430
12	Isoform switching of Cdc6 contributes to developmental cell cycle remodeling 2003 ·Developmental Biology ·(unknown), Thomas R. Coleman	14
13	XenopusCdc6 Performs Separate Functions in Initiating DNA Replication 2002 ·Molecular Biology of the Cell ·(unknown), Nancy Schek, (unknown), Thomas R. Coleman	19
14	The 3 Rs of Cdc6: Recruitment, Regulation, and Replication 2002 ·Current Biology ·Thomas R. Coleman	2
15	The Xenopus Cdc6 Protein Is Essential for the Initiation of a Single Round of DNA Replication in Cell-Free Extracts 1996 ·Cell ·Thomas R. Coleman, Phillip B. Carpenter, William G. Dunphy	346
16	Cell cycle regulation of a Xenopus Wee1-like kinase. 1995 ·Molecular Biology of the Cell ·Paul R. Mueller, Thomas R. Coleman, William G. Dunphy	274
17	Cdc2 regulatory factors 1994 ·Current Opinion in Cell Biology ·Thomas R. Coleman, William G. Dunphy	320
18	Negative regulation of the weel protein kinase by direct action of the nim1/cdr1 mitotic inducer 1993 ·Cell ·Thomas R. Coleman	157
19	Contributions of the β‐subunit to spectrin structure and function 1989 ·Cell Motility and the Cytoskeleton ·Thomas R. Coleman, Douglas J. Fishkind, Mark S. Mooseker, Jon S. Morrow	36
20	Functional diversity among spectrin isoforms 1989 ·Cell Motility and the Cytoskeleton ·Thomas R. Coleman, Douglas J. Fishkind, Mark S. Mooseker, Jon S. Morrow	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact